In 2023, the mortality value from cervix uteri malignant neoplasms for females in Japan was X thousands of deaths. From 2024 to 2028, a gradual increase in forecasted values signifies a steady uptick year-on-year. The mortality is expected to rise from 2.99 thousands in 2024 to 3.08 thousands in 2028, highlighting a slight upward trend.
- 2024-2025: 1.00% increase
- 2025-2026: 0.66% increase
- 2026-2027: 0.66% increase
- 2027-2028: 0.65% increase
The compound annual growth rate (CAGR) over this forecast period reflects an approximate 0.83% average growth per year.
Future trends to watch for include advances in healthcare interventions and screening technologies, which may alter the trajectory of mortality rates. Enhanced awareness and prevention programs could also contribute to significant changes in these patterns.
